Background and Clinical Features of a Unique and Mysterious Autoinflammatory Disease, Schnitzler Syndrome
International Journal of Molecular Sciences · 12.01.2025 · 26 (2) · 598
DOI: 10.3390/ijms26020598 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.01.2025. Verfasst von Györgyi Műzes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Division, Department of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary. Hauptthemen laut MEDLINE: Schnitzler Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Schnitzler syndrome is a unique autoinflammatory disease, of which 747 cases have been described worldwide to date. The main features of the syndrome are a triad of recurrent urticaria, monoclonal IgM gammopathy, systemic inflammation associated with recurrent fever, joint and bone pain, and atypical bone remodeling (osteosclerosis). The abnormal activation of the NLRP3 inflammasome produces IL-1, which drives the disease pathology, but it also involves IL-6 and IL-18. Unlike other autoinflammatory diseases, Schnitzler syndrome lacks evidence of the gene divergence causing the abnormal activation of NLRP3. However, mutations in the MEFV and MYD88 genes can be associated with the development of the disease. Due to its rarity, diagnosing the disease can be a challenging task. IL-1 inhibitors (i.e., anakinra, canakinumab, and rilonacept) are prominent in the treatment of the disease, but the IL-6 receptor inhibitor tocilizumab and the Bruton’s tyrosine kinase inhibitor ibrutinib are also promising alternatives. In this summary article, we aim to provide a comprehensive overview of the clinical and molecular background of the disease and potential therapeutic targets, based on the cases reported so far. We diagnosed a patient who, to the best of our knowledge, represents the 748th documented case of this specific pathology. In the context of this patient, we would also like to draw attention to the potential pathogenic role of two novel gene mutations (variants of the MEFV gene “c.2084A>G” and the F2 gene “3′UTR c.*97G>A”).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Division, Department of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary.
ORCID-Profile: Györgyi Műzes, Ferenc Sipos
Zitieren
APA
Műzes, G., & Sipos, F. (2025). Background and Clinical Features of a Unique and Mysterious Autoinflammatory Disease, Schnitzler Syndrome. International Journal of Molecular Sciences, 26(2), 598. https://doi.org/10.3390/ijms26020598
Vancouver
Műzes G, Sipos F. Background and Clinical Features of a Unique and Mysterious Autoinflammatory Disease, Schnitzler Syndrome. International Journal of Molecular Sciences. 2025;26(2):598. doi:10.3390/ijms26020598
BibTeX
@article{Mzes2025,
author = {Műzes, Györgyi and Sipos, Ferenc},
title = {Background and Clinical Features of a Unique and Mysterious Autoinflammatory Disease, Schnitzler Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {2},
pages = {598},
doi = {10.3390/ijms26020598}
}
EUVIMED